Targeted Drug Delivery to ACE2+ Cells Using Engineered Extracellular Vesicles: A Potential Therapeutic Approach for COVID-19.

Yao ZhangSheng-Jiao SongJin HeZhuo-Hua ZhaoKe ZhangYuan ZhangXing Li

Published in: Current pharmaceutical biotechnology (2024)

These findings indicate promising opportunities for engineered EVs as a novel nanomedicine carrier, offering valuable insights for therapeutic strategies against COVID-19 and other diseases.

Keyphrases

coronavirus disease
sars cov
cancer therapy
drug delivery
induced apoptosis
cell cycle arrest
respiratory syndrome coronavirus
angiotensin ii
angiotensin converting enzyme
cell death